A study in primary care of nomela® to exclude melanoma

A study in primary care of nomela®, an imaging analysis technology, to exclude cutaneous melanoma

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ISRCTN

Registry ID

ISRCTN15929734

Enrollment

1000

Registered

2018-01-23

Start date

2018-03-01

Completion date

Unknown

Last updated

2019-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cutaneous melanoma Cancer Cutaneous melanoma

Interventions

Patients being seen in primary care on whom referral to specialist review has been decided are asked to participate in this study if they satisfy the inclusion criteria and with lesions which satisfy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients presenting to primary care for assessment of suspicious pigmented skin lesions AND being referred to Dermatology Departments for specialist review on routine clinical decision. 2. Age 16 years and over. No gender discrimination.

Exclusion criteria

Exclusion criteria: 1. Other skin conditions considered by the primary care physician not to be pigmenyted moles 2. Patients unable or unwilling to give informed consent. 3. Age less than 16 years. 4. Lesions not suitable for the nomela® test

Design outcomes

Primary

Measure	Time frame
Sensitivity and specificity is mesaured using statistic analysis.	—

Secondary

Measure	Time frame
Testing the electronic reporting mechanism by nomela® to NHS records.	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026